Deals
Surging Chinese Online Demand Powers Aussie Vitamin Sales
This article is for subscribers only.
Booming Chinese demand for foreign-produced vitamins and supplements has helped one Australian company triple its share price in the past year and prompted another to explore a possible sale.
Blackmores Ltd. touched A$113.01 today from A$31.85 a year ago after Goldman Sachs Group Inc. recommended investors buy the Sydney-based stock, which it says will be spurred by online sales in China. Closely held producer Swisse Wellness Group Pty has engaged Goldman Sachs to examine a possible sale that may fetch as much as A$1 billion ($693 million), according to people with knowledge of the matter, who asked not to be identified as the information is private.